Correlation Between Salarius Pharmaceuticals and BiondVax Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and BiondVax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and BiondVax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and BiondVax Pharmaceuticals, you can compare the effects of market volatilities on Salarius Pharmaceuticals and BiondVax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of BiondVax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and BiondVax Pharmaceuticals.

Diversification Opportunities for Salarius Pharmaceuticals and BiondVax Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Salarius and BiondVax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and BiondVax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BiondVax Pharmaceuticals and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with BiondVax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BiondVax Pharmaceuticals has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and BiondVax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and BiondVax Pharmaceuticals

If you would invest  150.00  in Salarius Pharmaceuticals on August 31, 2024 and sell it today you would lose (5.00) from holding Salarius Pharmaceuticals or give up 3.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Salarius Pharmaceuticals  vs.  BiondVax Pharmaceuticals

 Performance 
       Timeline  
Salarius Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Salarius Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Salarius Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
BiondVax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BiondVax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BiondVax Pharmaceuticals is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Salarius Pharmaceuticals and BiondVax Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salarius Pharmaceuticals and BiondVax Pharmaceuticals

The main advantage of trading using opposite Salarius Pharmaceuticals and BiondVax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, BiondVax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiondVax Pharmaceuticals will offset losses from the drop in BiondVax Pharmaceuticals' long position.
The idea behind Salarius Pharmaceuticals and BiondVax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.